Neutralizing mechanisms of two human monoclonal antibodies against human cytomegalovirus glycoprotein 130/55. 1992

Y Ohizumi, and H Suzuki, and Y Matsumoto, and Y Masuho, and Y Numazaki
Virus Research Center, Sendai National Hospital, Japan.

The neutralization of human cytomegalovirus (HCMV) after adsorption to the cell surface at 4 degrees C was studied using two neutralizing monoclonal antibodies (C-23 and C-41) recognizing glycoprotein 130/55. HCMV adsorbed to cells was neutralized by C-23 (complement-independent), but not by C-41 (complement-dependent). Furthermore, the virus remained sensitive to C-23 for 120 min after shifting up from 4 degrees C to 37 degrees C, suggesting that C-23 might block an early stage of virus penetration into cells, and also that transition from virus attachment to virus penetration might be quite slow. The cell-to-cell infection of HCMV was also blocked only by C-23, and not by C-41. On the basis of the results presented here, we suggest that C-41 blocks the attachment of virus to the cell surface whereas C-23 prevents the penetration of virus into the cell.

UI MeSH Term Description Entries
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003080 Cold Temperature An absence of warmth or heat or a temperature notably below an accustomed norm. Cold,Cold Temperatures,Temperature, Cold,Temperatures, Cold
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000327 Adsorption The adhesion of gases, liquids, or dissolved solids onto a surface. It includes adsorptive phenomena of bacteria and viruses onto surfaces as well. ABSORPTION into the substance may follow but not necessarily. Adsorptions

Related Publications

Y Ohizumi, and H Suzuki, and Y Matsumoto, and Y Masuho, and Y Numazaki
August 1990, Journal of immunological methods,
Y Ohizumi, and H Suzuki, and Y Matsumoto, and Y Masuho, and Y Numazaki
May 1987, The Journal of general virology,
Y Ohizumi, and H Suzuki, and Y Matsumoto, and Y Masuho, and Y Numazaki
July 2012, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
Y Ohizumi, and H Suzuki, and Y Matsumoto, and Y Masuho, and Y Numazaki
August 2017, PLoS pathogens,
Y Ohizumi, and H Suzuki, and Y Matsumoto, and Y Masuho, and Y Numazaki
November 2008, BMC biotechnology,
Y Ohizumi, and H Suzuki, and Y Matsumoto, and Y Masuho, and Y Numazaki
January 1983, Comptes rendus des seances de l'Academie des sciences. Serie III, Sciences de la vie,
Y Ohizumi, and H Suzuki, and Y Matsumoto, and Y Masuho, and Y Numazaki
October 1992, Hybridoma,
Y Ohizumi, and H Suzuki, and Y Matsumoto, and Y Masuho, and Y Numazaki
April 1995, AIDS research and human retroviruses,
Y Ohizumi, and H Suzuki, and Y Matsumoto, and Y Masuho, and Y Numazaki
December 2024, Emerging microbes & infections,
Y Ohizumi, and H Suzuki, and Y Matsumoto, and Y Masuho, and Y Numazaki
January 2012, PLoS pathogens,
Copied contents to your clipboard!